Share Name Share Symbol Market Type Share ISIN Share Description
Profile Thera. LSE:PTP London Ordinary Share GB0001386225 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p - - - - - - - - -
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology - - - - 0.00

Profile Thera. (PTP) Latest News

Real-Time news about Profile Thera. (London Stock Exchange): 0 recent articles
More Profile Thera. News
Profile Thera. Takeover Rumours

Profile Thera. (PTP) Share Charts

1 Year Profile Thera. Chart

1 Year Profile Thera. Chart

1 Month Profile Thera. Chart

1 Month Profile Thera. Chart

Intraday Profile Thera. Chart

Intraday Profile Thera. Chart

Profile Thera. (PTP) Discussions and Chat

Profile Thera. Forums and Chat

Date Time Title Posts
27/9/200710:00The Profile Therapeutics Thread67
15/7/200210:49Anybody any views on PROFILE THERAPEUTICS26

Add a New Thread

Profile Thera. (PTP) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Profile Thera. trades in real-time

Profile Thera. (PTP) Top Chat Posts

bbbbb: good call ntv....judging by the share price the talks may be collapsing or some of the conditions outlined have not been met.
gopher: we have seen a number of technology groups sell out much to the disgust of the shareholders. (psion and biocompatibles) but Profile has not had such a high reputation or share price. I can't see the point of selling a company with turnover, no debt and a high R&D spend over the past few years at the current market cap.
bbbbb: ah ah... Profile Therapeutics plc ("Profile" or "the Company") The Board of Profile has noted the recent rise in the Company's share price and announces that it is in discussions that may or may not lead to a recommended cash offer being made for the Company. These discussions relate to a proposed offer at a price at or around the current share price of 50 pence and that the approach remainssubject to a number of pre-conditions. Shareholders should therefore note that, at this stage, there is no certainty as to the level of any such offer or indeed whether any firm offer will actually be made. This announcement is issued by the Board of Profile and not on behalf of the potential offeror. The Board of Profile is being advised by PricewaterhouseCoopers LLP.
Profile Thera. share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20180224 12:14:54